Hospital ‘Trauma Centers’ Charge Enormous Fees To Treat Minor Injuries and Send People Home
Tens of thousands of times a year, hospitals charge enormously expensive trauma alert fees for injuries so minor the patient is never admitted.
Jay Hancock
As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him
Reversing a trend in which contributions from drugmakers’ political committees and their employees have gone largely to Republicans, so far for 2020 the industry has tilted toward Democrats.
Rather Than Give Away Its COVID Vaccine, Oxford Makes a Deal With Drugmaker
Oxford University has signed an exclusive deal with AstraZeneca that gives the pharmaceutical giant sole rights with no guarantee of low prices.
Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image
Johnson & Johnson researchers working on a vaccine against the coronavirus are “just like the heroes in the hospitals” fighting to save patients, J&J CEO Alex Gorsky said on the “Today” show a few weeks ago.
Telehealth Will Be Free, No Copays, They Said. But Angry Patients Are Getting Billed.
Karen Taylor had been coughing for weeks when she decided to see a doctor in early April. COVID-19 cases had just exceeded 5,000 in Texas, where she lives.
High-Deductible Health Plans Fall From Grace In Employer-Based Coverage
With low unemployment, companies have slowed enrollment in the plans and in some cases reverted to traditional plans to attract employees.
With workers harder to find and Obamacare’s tax on generous coverage postponed, employers are hitting pause on a feature of job-based medical insurance much hated by employees: the high-deductible health plan.
Despite Insurers’ Tactical Win On ACA’s Cost-Sharing Payments, Uncertainty Lingers
Health insurers have won powerful allies in a fight over federal subsidies that President Donald Trump has threatened to cancel for millions of people who buy insurance through the Affordable Care Act.
